Janney Montgomery Scott LLC Amgen Inc Transaction History

Janney Montgomery Scott LLC

$32.8 Billion
Q2 2024

A detailed history of Janney Montgomery Scott LLC transactions in Amgen Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 427,202 shares of AMGN stock, worth $144 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

427,202

Previous 313,781 36.15%

Holding current value

$144 Million

Previous $89.2 Million 49.62%

% of portfolio

0.41%

Previous 0.27%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	BUY	$262.75 - $319.31 $29.8 Million - $36.2 Million	113,421 Added 36.15%	427,202 $133 Million
Q1 2024 May 01, 2024	BUY	$268.87 - $324.56 $5.87 Million - $7.08 Million	21,824 Added 7.48%	313,781 $89.2 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $5.82 Million - $6.57 Million	-22,780 Reduced 7.24%	291,957 $84.1 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $4.45 Million - $5.53 Million	20,354 Added 6.91%	314,737 $84.6 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $63.1 Million - $74.6 Million	294,383 New	294,383 $65.4 Million
Q4 2022 Feb 01, 2023	BUY	$229.03 - $291.01 $6.1 Million - $7.75 Million	26,632 Added 11.18%	264,922 $69.6 Million
Q3 2022 Oct 25, 2022	BUY	$224.46 - $253.15 $53.5 Million - $60.3 Million	238,290 New	238,290 $53.7 Million
Q1 2021 Apr 27, 2021	SELL	$221.91 - $258.6 $57.2 Million - $66.6 Million	-257,621 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $5.23 Million - $6.23 Million	24,182 Added 10.36%	257,621 $59.2 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $1.66 Million - $1.84 Million	-7,055 Reduced 2.93%	233,439 $59.3 Million
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $7.7 Million - $9.45 Million	38,929 Added 19.31%	240,494 $56.7 Million
Q1 2020 Apr 30, 2020	BUY	$182.24 - $241.7 $3.73 Million - $4.95 Million	20,461 Added 11.3%	201,565 $40.9 Million
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $1.14 Million - $1.47 Million	6,048 Added 3.45%	181,104 $43.7 Million
Q3 2019 Oct 29, 2019	SELL	$174.11 - $208.62 $228,606 - $273,918	-1,313 Reduced 0.74%	175,056 $33.9 Million
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $40,008 - $46,898	240 Added 0.14%	176,369 $32.5 Million
Q1 2019 Apr 30, 2019	SELL	$180.87 - $203.88 $948,663 - $1.07 Million	-5,245 Reduced 2.89%	176,129 $33.5 Million
Q4 2018 Feb 01, 2019	BUY	$178.4 - $208.25 $422,808 - $493,552	2,370 Added 1.32%	181,374 $35.3 Million
Q3 2018 Nov 05, 2018	SELL	$185.29 - $208.89 $509,176 - $574,029	-2,748 Reduced 1.51%	179,004 $37.1 Million
Q2 2018 Jul 24, 2018	BUY	$166.05 - $186.51 $1 Million - $1.13 Million	6,039 Added 3.44%	181,752 $33.6 Million
Q1 2018 Apr 19, 2018	SELL	$169.43 - $198.0 $6.19 Million - $7.24 Million	-36,548 Reduced 17.22%	175,713 $30 Million
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $1.57 Million - $1.75 Million	9,303 Added 4.58%	212,261 $36.9 Million
Q3 2017 Nov 15, 2017	BUY	$167.29 - $191.0 $34 Million - $38.8 Million	202,958	202,958 $37.8 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $180B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Amgen Inc Transaction History